PRIA Logo™
119-s-998119th CongressWALLET

Medical Supply Chain Resiliency Act

Sponsored By: Senator Tillis, Thomas [R-NC]

Introduced

Summary

trusted trade partner agreements to secure medical goods is the core idea. This bill would let the President negotiate and enforce pacts that cut or change duties and harmonize rules for medical devices, drugs, and their inputs to protect U.S. national security and public health.

Show full summary
  • Families and patients would see a more reliable flow of medical devices and pharmaceuticals, especially during public health emergencies, through supplier diversification and faster cross-border movement.
  • Manufacturers, researchers, and investors would gain stronger IP protections, regulatory cooperation, and potential access to government procurement that could encourage investment and expanded manufacturing capacity.
  • Congress and federal agencies would get built-in oversight. The President must notify Congress 60 days before talks, report every 180 days on negotiations, provide a 60-day implementation report, and Congress has an initial 30-day review with the power to disapprove. The U.S. Trade Representative would monitor compliance and the President could act on violations with defined timelines.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

4 provisions identified: 2 benefits, 0 costs, 2 mixed.

Rules for choosing trusted partners

If enacted, the President would need to consider specific criteria before entering negotiations. Criteria include the partner's willingness, keeping trade open in emergencies, following trade commitments, reducing unnecessary barriers, rule of law, and strong intellectual property and regulatory practices. This aims to favor partners whose practices support U.S. supply security and public health.

Monitoring and enforcement for partners

If enacted, the U.S. Trade Representative must periodically check whether trusted partners keep their commitments. If the Trade Representative finds a partner failing to comply, it must report findings and recommended actions to the President. The President would have 30 days to decide and must implement chosen corrective actions within 15 days. Actions can include suspending an agreement or removing emergency exemptions.

President can negotiate medical trade pacts

If enacted, the bill would let the President negotiate and join "trusted trade partner" agreements for medical goods. These pacts could cut or remove import duties, quotas, and other trade barriers. They could also expand which suppliers can compete for government medical contracts. Agreements may allow partners to skip export or import limits on covered medical goods during public health emergencies.

New congressional review and notice rules

If enacted, the bill would give Congress more notice and reports on negotiations. The President must notify Congress 60 days before starting talks. The President must give a detailed report at least 60 days before entering an agreement. The President must also send status reports every 180 days. A submitted agreement cannot take effect until Congress finishes a review that starts at 30 days and can be extended by 60 and then 30 more days.

Sponsors & CoSponsors

Sponsor

Tillis, Thomas [R-NC]

NC • R

Cosponsors

  • Sen. Coons, Christopher A. [D-DE]

    DE • D

    Sponsored 3/12/2025

  • Sen. Cornyn, John [R-TX]

    TX • R

    Sponsored 3/12/2025

  • Sen. Bennet, Michael F. [D-CO]

    CO • D

    Sponsored 3/12/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation